Phase IIb Multicenter Randomized Comparative Study of Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for Chronic Inflammatory Bowel Disease
Phase of Trial: Phase II
Latest Information Update: 28 Nov 2018
Price : $35 *
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms PneumoMICI
- 25 Oct 2018 Planned primary completion date changed from 1 Dec 2021 to 1 Dec 2019.
- 17 Oct 2017 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 17 Oct 2017 Planned primary completion date changed from 1 Dec 2020 to 1 Dec 2021.